Gene ID | Gene Name ▼ | Gene Symbol | Disease Ontology |
---|---|---|---|
125513331 | probable UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase SPINDLY |
|
|
125538118 | probable UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase SEC |
|
|
125510102 | polygalacturonate 4-alpha-galacturonosyltransferase |
|
|
125508334 | phosphatidylinositol N-acetylglucosaminyltransferase subunit A-like |
|
|
125545473 | peptidyl serine alpha-galactosyltransferase |
|
|
125528360 | mixed-linked glucan synthase 2-like |
|
|
125515947 | mannosyltransferase APTG1 |
|
|
125515241 | mannose-P-dolichol utilization defect 1 protein homolog 2 |
|
|
125539143 | inositol phosphorylceramide glucuronosyltransferase 1-like |
|
|
125513813 | inositol phosphorylceramide glucuronosyltransferase 1-like |
|
|
125539138 | inositol phosphorylceramide glucuronosyltransferase 1-like |
|
|
125553839 | indole-3-acetate beta-glucosyltransferase-like |
|
|
125522188 | hydroxyproline O-galactosyltransferase HPGT3-like |
|
|
125518984 | hydroxyproline O-galactosyltransferase HPGT1 |
|
|
125550300 | hydroxyproline O-galactosyltransferase GALT5-like |
|
|
125546121 | hydroxyproline O-galactosyltransferase GALT3 |
|
|
125526612 | hydroxyproline O-galactosyltransferase GALT2-like |
|
|
125507754 | hydroxyproline O-galactosyltransferase GALT2-like |
|
|
125507760 | hydroxyproline O-galactosyltransferase GALT2-like |
|
|
125520080 | hydroxyproline O-galactosyltransferase GALT2-like |
|
|
125529384 | hydroxyproline O-arabinosyltransferase NOD3-like |
|
|
125543709 | hydroxyproline O-arabinosyltransferase 3-like |
|
|
125543704 | hydroxyproline O-arabinosyltransferase 3-like |
|
|
125543713 | hydroxyproline O-arabinosyltransferase 3-like |
|
|
125550477 | hydroquinone glucosyltransferase-like |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024